How Long Do You Stay on 2.5mg Mounjaro?

The four-week rule: why the 2.5mg period is fixed by design

The licensed schedule for tirzepatide starts at 2.5mg for four weeks, then steps to 5mg. That structure comes from the SmPC, the clinical specification Eli Lilly submitted to regulators when Mounjaro was approved. It is not arbitrary. Tirzepatide activates two gut-hormone receptors simultaneously, and the starter dose gives the gastrointestinal system a month to adapt before a therapeutic dose begins in earnest. The 5mg dose is where treatment proper starts for most people.

A question our prescribers hear most weeks is whether staying at 2.5mg longer will produce results. Honestly, the answer is usually no, at least not the kind the trial data shows. SURMOUNT-1, which involved 2,539 adults, reported average body-weight reductions of around 20–21% at the 15mg maintenance dose over 72 weeks. Those figures come from people who moved through the titration schedule; 2.5mg was never the dose being measured for efficacy. You can read the clinical rationale for this titration pathway in the BNF entry for tirzepatide.

So for the majority of patients, how long you stay on 2.5mg Mounjaro is exactly four weeks. The decision to move on is straightforward when side effects are manageable and the body has had its settling-in period.

When staying longer at 2.5mg is the right call

Four weeks is the standard. It is not a hard ceiling when someone is still struggling with nausea, vomiting or digestive discomfort that hasn't eased. In those cases, a prescriber may decide to hold at 2.5mg for a further four weeks rather than push through an increase that could make things harder.

This is one of the clearest illustrations of why clinical oversight matters throughout treatment, not just at the start. Blanket rules don't fit every body. Someone who experienced significant nausea in the first fortnight and found it settling by week three is in a different position to someone still vomiting at week four. The question of whether it's clinically appropriate to extend the 2.5mg period has a genuine answer, but that answer is personal.

The NHS guidance on weight-management injections confirms that titration timing is a matter for the prescriber, not a fixed rule patients manage themselves. Holding at a lower dose when needed is sound clinical practice, not a failure. What it isn't is a reason to remain at 2.5mg indefinitely, at some point, if the starter dose cannot be tolerated even at four or eight weeks, that's a conversation about whether this medicine is right for you at all.

The factors that shape your prescriber's decision

When a prescriber reviews your progress at the four-week mark, they're weighing several things at once. How manageable were side effects? Are they still present or have they resolved? Have you lost any weight, even a modest amount is a reasonable early signal? Are there any new health details that affect the picture?

At nume, that review happens before every repeat order. A real clinician reads your update; no automated system decides your next step. If the clinical picture supports moving to 5mg, the prescription reflects that. If there's a reason to hold, the prescriber will say so and explain why. You can see more about how long most people stay at 5mg once that transition happens, the same logic of tolerability plus therapeutic progress applies at each rung of the schedule.

It's also worth knowing that the titration doesn't stop at 5mg. The licensed strengths run from 2.5mg through to 15mg, and the full schedule typically spans around six months of stepping up before someone reaches their maintenance dose. How long someone stays at 15mg is a separate question, one that depends on sustained response and ongoing clinical review. For context on what treatment might cost across that period, the Mounjaro pricing page sets out what's included in a private prescription.

What this means in practice

For most people: four weeks at 2.5mg, then on to 5mg, reviewed by a prescriber before each step. The starter dose does its job and you move forward. Simple.

For people with a harder start (more persistent nausea, a body that takes longer to adapt) the timeline bends to fit. An additional four weeks at 2.5mg is not unusual, and it does not compromise the overall outcome if it means you can then tolerate the therapeutic doses properly. The guidance on how long to stay at 2.5mg consistently comes back to the same point: your prescriber decides, based on you.

The NHS tirzepatide patient page on the NHS website is a clear, plain-English reference if you want to read the official patient-level description of the dosing schedule and common side effects. It does not replace a prescriber's advice, but it is a reliable starting point.

If you'd like a prescriber to review your situation and work through your titration plan with you, check your eligibility with our team, the consultation is free, and a GPhC-registered prescriber will review your answers the same day.